ScripThe hemophilia market is a challenging and competitive field but Sanofi is confident that fitusiran, which has just been given the green light by the US Food and Drug Administration (28 March), has th
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eyenovia, Betaliq Will Have Combined C
Pink SheetAltuvoct (efanesoctocog alfa), Sobi’s once-weekly injection for hemophilia A, is to be reimbursed in England, after the company and other stakeholders addressed the key uncertainties that had previous
ScripA total of 37 novel drugs were approved by the European Commission in 2024, a figure only marginally higher than the 36 products that were given the go-ahead in 2023. The 2024 and 2023 figures for new